News

JAZZ

Moleculin Biotech (MBRX): Progress Toward Acute Leukemia Therapy

Edward Kim | Equities.com |

Moleculin Biotech is developing treatments for acute myeloid leukemia (AML) and other cancers.


Investing in the Best Canadian Biotech Stocks

The Life Sciences Report | Equities.com |

You may not have thought to look northward for biotech innovators, but Bloom Burton & Co. cofounder and President Brian Bloom can show you some truly hot Canadian companies with compelling


Why are So Many Health Care Companies Moving to Ireland?

Jianyu Zhao | Equities.com |

Covidien (COV) surged to a 52-week high of $86.75 per share on June 16, after rival medical device manufacturer Medtronic (MDT) announced it would buy the Irish company for $42.9 billion in a


Ariad Pharmaceuticals (ARIA) Jumps on More Buyout Rumors

Joel Anderson | Equities.com |

Shares of small-cap pharma Ariad Pharmaceuticals (ARIA) were trading higher on Friday after rumors were started by British paper The Daily Mail that Jazz Pharmaceuticals (JAZZ) was interested


FDA Approves Antares Pharma's Otrexup for Arthritis and Psoriasis

Andrew Klips | Equities.com |

Shares of self injection drug delivery technology company Antares Pharma, Inc. (ATRS) are trading higher on Monday after the U.S. Food and Drug Administration approved Otrexup, a once-per-week


Keys to a Wining Stock Market Strategy

Mike Turner | Equities.com |

Hello Tom, Quote worth Quoting Again One of the common failings among honorable people is a failure to appreciate how thoroughly dishonorable some other people can


Equities Sector Coverage: Dow Closes Above 13,000 As Investors Shrug Off More Cliff News

Sector Recap | Equities.com |

Initial Jobless Claims came in at 393,000 in the latest week, well above the 350,000 recessionary threshold. The Dow Jones Industrial Average rebounded to 13,062.56 then dipped to 12,961.92 then


Equities Sector Coverage: Stocks Close Lower on No Progress for Fiscal Cliff

Sector Recap | Equities.com |

The S&P Case/Shiller 20-City Home Price Index rose 0.3% month over month in September, the sixth consecutive monthly rise, and rose 3.0% year over year. The index is up 9.0% from its March


Stocks Under $10: Are These Tech Stocks Still Attractive?

Andrew Klips | Equities.com |

At www.ValuEngine.com we show that the Computer & Technology sector is 2.2% undervalued. All seven of the stocks in today’s table have complete ValuEngine data and we have enough price data


Equities Sector Coverage: Stocks Sink As Central Bank Excitement Wears Off

Sector Recap | Equities.com |

The NY Fed Empire State Survey declined to a weaker than expected reading of -10.41 in September.  The Dow Jones Industrial Average traded down to 13,526.83 going into the final half hour of


Sponsored Financial Content

Market Movers